✦ LIBER ✦

A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study

✍ Scribed by C. Villanueva; A. Awada; M. Campone; J.P. Machiels; T. Besse; E. Magherini; F. Dubin; D. Semiond; X. Pivot

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicentre, phase II study evaluating c

✍ P. Fumoleau; R. Largillier; C. Clippe; V. Dièras; H. Orfeuvre; T. Lesimple; S. C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 201 KB

A phase I study of vinflunine in combina

✍ M. Campone; N. Isambert; E. Bourbouloux; H. Roché; J. Bonneterre; G. Milano; P. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 369 KB

Phase II study of irinotecan plus capeci

✍ Keun Seok Lee, In Hae Park, Byung-Ho Nam, Jungsil Ro 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 186 KB

Bortezomib/docetaxel combination therapy

✍ Awada, A; Albanell, J; Canney, P A; Dirix, L Y; Gil, T; Cardoso, F; Gascon, P; P 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

An all-oral combination of metronomic cy

✍ Zhonghua Wang; Jingsong Lu; Shiangjiin Leaw; Xiaonan Hong; Jialei Wang; Zhimin S 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 223 KB

Phase II study of oral vinorelbine in co

✍ Alison Jones; Mary O’Brien; Harald Sommer; Elzbieta Nowara; Anja Welt; Tadeusz P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 364 KB